Deltex Medical Group Plc engages in manufacturing and sale of advanced haemodynamic monitoring technologies. It operates through the following four segments: Probes, Monitors, Third Party Products and Other. Its products include ODM+, Dopplers Probes, HD Impedeance Cardiography, Cerebral Oximetry and Laryngoscopes. The company was founded on January 6, 2000 and is headquartered in Chichester, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company